1. The role of total alimentary limb length in Roux-en-Y gastric bypass: a systematic review
- Author
-
Roc W. Bauman, Iain H. McKillop, Kyle J. Thompson, Abdelrahman Nimeri, Selwan Barbat, Alexander Abdurakhmanov, Lauren Poliakin, Alice Wang, Naresh Sundaresan, Keith S. Gersin, Vilok Vijayanagar, and Timothy S. Kuwada
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Ovid medline ,Gastric bypass ,Gastric Bypass ,Protein-Energy Malnutrition ,Weight loss ,Weight Loss ,medicine ,Humans ,Obesity ,skin and connective tissue diseases ,Alimentary limb ,business.industry ,Malnutrition ,nutritional and metabolic diseases ,medicine.disease ,Roux-en-Y anastomosis ,humanities ,Limb length ,Obesity, Morbid ,Surgery ,Search terms ,medicine.symptom ,business ,human activities - Abstract
Roux-en-Y gastric bypass (RYGB) is an established surgical treatment for obesity. Variations in limb length during RYGB procedures have been investigated for optimizing weight loss while minimizing nutritional deficiencies. The role of the total alimentary limb length (TALL; Roux limb plus common channel [CC]), however, is poorly defined.Compare TALL in RYGB procedures for weight loss outcomes and malnutrition.Systematic review.Ovid Medline and PubMed databases were searched for entries between 1993 and 2020. Search terms included "gastric bypass" and "TALL." Two independent reviewers screened the results.A total of 21 studies measured TALL in RYGB. Of these, 4 of 6 reported a relationship between TALL and weight loss. Additionally, 11 studies reported that when TALL was ≤400 cm and CC200 cm, 3.4% to 63.6% of patients required limb lengthening for protein malnutrition.The majority of studies on RYGB do not report TALL length. There is some evidence that weight loss is affected by shortening TALL, while a TALL ≤400 cm with CC200 should be avoided due to severe protein malnutrition. More studies on the effect of TALL are needed.
- Published
- 2022